Brand Name: APHEXDA. Generic Name: (motixafortide). APHEXDA (motixafortide) is used with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.
APHEXDA is a prescription drug that in combination with filgrastim (a granulocyte-colony stimulating factor [G-CSF]) mobilizes hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.
Brand Name: | APHEXDA |
Generic Name: | motixafortide |
Strength: | For Injection: 62 mg as a lyophilized powder in a single-dose vial for reconstitution. |
Manufacturer: | BioLineRx |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “APHEXDA (motixafortide)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for APHEXDA (motixafortide) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.